Home › Free Stock Grades › TXG
10x Genomics, Inc. (TXG) Stock Grade
TXG · Healthcare
A+
Market Cap
$2.0B
P/E Ratio
—
Revenue Growth (YoY)
+5.3%
Net Margin
-6.8%
Return on Equity
—
Dividend Yield
None
About 10x Genomics, Inc.'s fundamentals
10x Genomics is a healthcare information services company with a $2.0 billion market cap that generated 5.3% year-over-year revenue growth in its latest period. The company is currently unprofitable, with a net margin of -6.8%, and reported a net loss in its latest annual statement. Despite the accounting losses, 10x Genomics maintains positive free cash flow, indicating the business is generating cash from operations even as it operates at a net loss.